• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEM CORP TERUMO CDI 500 BLOOD PARAMETER MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEM CORP TERUMO CDI 500 BLOOD PARAMETER MONITOR Back to Search Results
Model Number 500AVHCT
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/03/2014
Event Type  malfunction  
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the pco2 reading on the blood parameter monitor (bpm) was drifting.As a result, an alternate device was employed.The surgical procedure was completed successfully.There were no delays, no blood loss, or no adverse consequences to the pt.Per clinical review on (b)(6) 2014: the bpm was gas calibrated with the 540 calibrator prior to use and the calibration passed.Acetate prime solution (plasmalyte) was used per normal practice, by the prime was buffered with sodium bicarbonate and the prime ph was >7.0.On the initiation of cpb and prior to the first in-vivo recalibration, the partial pressure of carbon dioxide (pco2) was measured on the bpm as about 80mmhg.The lab analyzer measured about 40 mmhg.After the in-vivo recalibration and a number of other re-calibrations, the paco2 measurement of the bpm varied significantly from the lab analyzer and in most cases the bpm was displaying high numbers than the lab analyzer.The other measurements (other parameters) of the bpm were tracking very closely to the lab analyzer.The perfusionist (ccp) stated that no unusual medications were used during the case.The ccp stated it was obvious the bpm was not accurate (in regards to pco2) and no pt interventions were done, due to the pco2 measures of the bpm.The cause was completed successfully, without delay and without associated blood loss.There was no harm observed or reported.
 
Manufacturer Narrative
Evaluation is in progress, but not yet concluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO CDI 500 BLOOD PARAMETER MONITOR
Type of Device
CDI 500
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEM CORP
ann arbor MI
Manufacturer Contact
jan winder
6200 jackson rd.
ann arbor, MI 48103
7346634145
MDR Report Key3832583
MDR Text Key16448962
Report Number1828100-2014-00204
Device Sequence Number1
Product Code DRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K972962
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500AVHCT
Device Catalogue Number500AVHCT
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/25/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/06/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
LAB ANALYZER
-
-